Unnamed: 0,title,date,stock,sentiment
565310.0,84 Biggest Movers From Yesterday,2020-05-08 05:34:00-04:00,GNMK,neutral
565311.0,Mid-Afternoon Market Update: Dow Jumps 270 Points; Twilio Shares Rise On Upbeat Results,2020-05-07 14:36:00-04:00,GNMK,positive
565312.0,68 Stocks Moving In Thursday's Mid-Day Session,2020-05-07 12:42:00-04:00,GNMK,neutral
565313.0,Mid-Day Market Update: Crude Oil Rises 8%; Vista Outdoor Shares Plunge,2020-05-07 12:00:00-04:00,GNMK,negative
565314.0,GenMark shares are trading higher. The company reported a common stock offering of 7.2 million shares at $9.65 per share.,2020-05-07 11:22:00-04:00,GNMK,positive
565315.0,GenMark Diagnostics: P/E Ratio Insights,2020-05-07 10:39:00-04:00,GNMK,neutral
565316.0,Mid-Morning Market Update: Markets Open Higher; Bristol-Myers Squibb Tops Q1 Estimates,2020-05-07 10:22:00-04:00,GNMK,positive
565317.0,"The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500",2020-05-07 07:41:00-04:00,GNMK,negative
565318.0,66 Biggest Movers From Yesterday,2020-05-07 05:52:00-04:00,GNMK,neutral
565319.0,GenMark Prices 7.2M Share Public Offering of Common Stock @$9.65/Share,2020-05-07 05:36:00-04:00,GNMK,positive
565320.0,"GenMark Reports Commencement Of Common Stock Offering, No Size Disclosed",2020-05-06 16:03:00-04:00,GNMK,negative
565321.0,"The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle",2020-05-06 08:42:00-04:00,GNMK,positive
565322.0,Stocks That Hit 52-Week Highs On Tuesday,2020-05-05 10:48:00-04:00,GNMK,neutral
565323.0,"The Daily Biotech Pulse: Bio-Rad's Coronavirus Test Gets EUA, Beat-And-Raise Quarter From GenMark, Adverum's Positive Gene Therapy Readout",2020-05-05 08:00:00-04:00,GNMK,positive
565324.0,28 Stocks Moving in Tuesday's Pre-Market Session,2020-05-05 07:16:00-04:00,GNMK,neutral
565325.0,"GenMark Diagnostics shares are trading higher after the company reported better-than-expected Q1 EPS and sales results. UPDATE: Shares have since reversed, now lower.",2020-05-05 06:39:00-04:00,GNMK,positive
565326.0,"Needham Maintains Buy on GenMark Diagnostics, Raises Price Target to $15",2020-05-05 06:22:00-04:00,GNMK,neutral
565327.0,5 Stocks Moving In Monday's After-Hours Session,2020-05-04 17:12:00-04:00,GNMK,neutral
565328.0,GenMark Diagnostics shares are trading higher after the company reported better-than-expected Q1 EPS and sales results.,2020-05-04 16:15:00-04:00,GNMK,positive
565329.0,GenMark Diagnostics Sees FY20 Sales $120-$130M,2020-05-04 16:15:00-04:00,GNMK,neutral
565330.0,"GenMark Diagnostics Q1 EPS $(0.120) Beats $(0.140) Estimate, Sales $38.700M Beat $29.770M Estimate",2020-05-04 16:14:00-04:00,GNMK,neutral
565331.0,GenMark Diagnostics Announces Scott Mendel Appointed CEO,2020-05-04 16:07:00-04:00,GNMK,neutral
565332.0,20 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-05-04 07:44:00-04:00,GNMK,neutral
565333.0,The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace,2020-05-03 08:45:00-04:00,GNMK,neutral
565334.0,"The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1",2020-04-30 07:19:00-04:00,GNMK,positive
565335.0,"The Daily Biotech Pulse: Inovio's MERS Vaccine Data, Fast Track Designation For Erytech, FDA Approves Higher Dose Of Merck's Keytruda",2020-04-29 08:40:00-04:00,GNMK,positive
565336.0,Stocks That Hit 52-Week Highs On Tuesday,2020-04-28 10:18:00-04:00,GNMK,neutral
565337.0,Stocks That Hit 52-Week Highs On Friday,2020-04-24 10:33:00-04:00,GNMK,neutral
565338.0,"The Daily Biotech Pulse: FDA Approves Sanofi's Meningococcal Vaccine, Pluristem Secures $54M In Funding For COVID-19 Treatment, Oric Pharma Prices IPO",2020-04-24 08:38:00-04:00,GNMK,positive
565339.0,76 Biggest Movers From Yesterday,2020-04-24 04:42:00-04:00,GNMK,neutral
565340.0,Shares of several healthcare companies are trading higher. Movement appears market-related as equities gain amid a rebound in oil prices.,2020-04-23 11:27:00-04:00,GNMK,positive
565341.0,Stocks That Hit 52-Week Highs On Thursday,2020-04-23 10:41:00-04:00,GNMK,neutral
565342.0,"The Daily Biotech Pulse: FDA Nod For Immunomedics, Lilly's Solid Q1 Beat, Predictive Oncology Restructures Debt",2020-04-23 07:53:00-04:00,GNMK,negative
565343.0,Shares of several healthcare companies are trading higher as equities gain amid oil prices potentially stabilizing following the recent crash.,2020-04-22 12:03:00-04:00,GNMK,positive
565344.0,Stocks That Hit 52-Week Highs On Wednesday,2020-04-22 10:20:00-04:00,GNMK,neutral
565345.0,"The Daily Biotech Pulse: Immunic To Develop COVID Treatment, Gilead Strikes IO Partnership",2020-04-22 07:51:00-04:00,GNMK,negative
565346.0,Stocks That Hit 52-Week Highs On Tuesday,2020-04-21 10:30:00-04:00,GNMK,neutral
565347.0,"The Daily Biotech Pulse: Applied DNA Begins Validating COVID-19 Test, Cara's Positive Readout, Novan Explores Strategic Alternatives",2020-04-21 08:19:00-04:00,GNMK,positive
565348.0,Stocks That Hit 52-Week Highs On Monday,2020-04-20 10:25:00-04:00,GNMK,neutral
565349.0,Shares of several healthcare companies are trading higher as markets gain on positive coronavirus outlook. Other potential positive sector catalysts include demand for therapies and medical supplies amid the coronavirus pandemic.,2020-04-14 10:59:00-04:00,GNMK,positive
565350.0,30 Stocks Moving in Thursday's Pre-Market Session,2020-04-09 07:10:00-04:00,GNMK,neutral
565351.0,86 Biggest Movers From Yesterday,2020-04-09 05:43:00-04:00,GNMK,negative
565352.0,65 Stocks Moving In Wednesday's Mid-Day Session,2020-04-08 12:35:00-04:00,GNMK,neutral
565353.0,Shares of several healthcare companies are trading higher amid overall market strength. Several companies in the sector may also be benefiting from increased demand for therapies and medical supplies amid the coronavirus pandemic. UPDATE: Shares of some names in the sector moved higher later in the session following news that US Senator Sanders has suspended his presidential campaign.,2020-04-08 09:34:00-04:00,GNMK,positive
565354.0,"The Daily Biotech Pulse: Genmark Pre-Announces Q1 Outperformance, Sage to Eliminate 53% of Workforce, Keros IPO",2020-04-08 07:53:00-04:00,GNMK,neutral
565355.0,30 Stocks Moving in Wednesday's Pre-Market Session,2020-04-08 07:24:00-04:00,GNMK,neutral
565356.0,A Peek Into The Markets: US Stock Futures Flat Ahead Of Fed Minutes,2020-04-08 05:51:00-04:00,GNMK,neutral
565357.0,"5 Stocks To Watch For April 8, 2020",2020-04-08 05:04:00-04:00,GNMK,neutral
565358.0,6 Stocks Moving In Tuesday's After-Hours Session,2020-04-07 16:41:00-04:00,GNMK,neutral
565359.0,GenMark Diagnostics shares are trading higher after the company raised FY20 sales guidance.,2020-04-07 16:09:00-04:00,GNMK,positive
565360.0,GenMark Raises FY20 Sales Guidance From $100M-$110M To $112M-$122M vs $105.6M Estimate,2020-04-07 16:04:00-04:00,GNMK,neutral
565361.0,"Genmark Diagnostics Sees Q1 Sales ~$38.7M, Gross Margin ~40%",2020-04-07 16:03:00-04:00,GNMK,negative
565362.0,20 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-03-25 07:35:00-04:00,GNMK,neutral
565363.0,30 Stocks Moving in Wednesday's Pre-Market Session,2020-03-25 07:08:00-04:00,GNMK,neutral
565364.0,"The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test",2020-03-24 08:20:00-04:00,GNMK,negative
565365.0,111 Biggest Movers From Yesterday,2020-03-24 04:18:00-04:00,GNMK,neutral
565366.0,GenMark Shares Spike To Recent High As Traders Circulate Mar. 20-Dated Contract Data Reporting Doc From Dept. Of Health & Human Services For 'Development of GenMark Dx ePlexÂ® Respiratory Pathogen v2 Panel',2020-03-23 15:40:00-04:00,GNMK,negative
565367.0,71 Stocks Moving In Monday's Mid-Day Session,2020-03-23 12:31:00-04:00,GNMK,neutral
565368.0,Shares of several healthcare companies are trading lower amid market volatility. Sunday's fiscal stimulus bill failed a procedural senate vote while the Fed Monday morning announced further stimulus measures to support liquidity.,2020-03-23 11:31:00-04:00,GNMK,negative
565369.0,36 Stocks Moving in Monday's Pre-Market Session,2020-03-23 07:38:00-04:00,GNMK,neutral
565370.0,105 Biggest Movers From Friday,2020-03-23 05:21:00-04:00,GNMK,neutral
565371.0,Mid-Afternoon Market Update: Dow Tumbles Over 600 Points; Bellerophon Therapeutics Shares Surge,2020-03-20 14:56:00-04:00,GNMK,positive
565372.0,Mid-Day Market Update: Crude Oil Down Over 10%; GenMark Diagnostics Shares Spike Higher,2020-03-20 12:18:00-04:00,GNMK,negative
565373.0,70 Stocks Moving In Friday's Mid-Day Session,2020-03-20 12:02:00-04:00,GNMK,neutral
565374.0,Why GenMark's Stock Is Trading Higher Today,2020-03-20 11:31:00-04:00,GNMK,neutral
565375.0,Mid-Morning Market Update: Markets Mostly Higher; Hibbett Sports Reports Mixed Q4 Results,2020-03-20 10:17:00-04:00,GNMK,neutral
565376.0,GenMark Diagnostics shares are trading higher after the company received FDA Emergency Use Authorization for its ePlex SARS-CoV-2 test.,2020-03-20 09:52:00-04:00,GNMK,negative
565377.0,31 Stocks Moving in Friday's Pre-Market Session,2020-03-20 07:26:00-04:00,GNMK,neutral
565378.0,GenMark Receives FDA Emergency Use Authorization for its ePlex SARS-CoV-2 Test,2020-03-20 05:26:00-04:00,GNMK,negative
565379.0,144 Biggest Movers From Friday,2020-03-16 05:03:00-04:00,GNMK,neutral
565380.0,88 Stocks Moving In Friday's Mid-Day Session,2020-03-13 12:38:00-04:00,GNMK,neutral
565381.0,GenMark Diagnostics shares are trading lower. Weakness potentially tied to profit taking as the stock has been volatile since the company filed an application with the FDA for Emergency Use Authorization for its ePlex coronavirus test.,2020-03-13 10:54:00-04:00,GNMK,negative
565382.0,"GenMark Diagnostics shares are trading higher amid the continued global spread of the coronavirus. The company recently filed an application with the FDA for Emergency Use Authorization for its ePlex coronavirus test. UPDATE: Shares have since reversed, now lower.",2020-03-12 09:11:00-04:00,GNMK,negative
565383.0,90 Biggest Movers From Yesterday,2020-03-12 06:10:00-04:00,GNMK,neutral
565384.0,GenMark Diagnostics Files For Emergency Use Authorization For COVID-19 Test,2020-03-11 09:06:00-04:00,GNMK,negative
565385.0,"Benzinga Pro's Top 5 Stocks To Watch For Wed., Mar. 11, 2020: TDOC, GNMK, HLT, MEET, AYTU",2020-03-11 08:26:00-04:00,GNMK,positive
565386.0,GenMark Diagnostics Announces Submission Of Emergency Use Authorization For Its ePlex SARS-CoV-2 Test For Coronavirus,2020-03-11 08:01:00-04:00,GNMK,negative
565387.0,GenMark Diagnostics Option Alert: Mar 20 $2.5 Calls Sweep (13) near the Ask: 307 @ $1.65 vs 2041 OI; Earnings 4/28 After Close [est] Ref=$4.2,2020-03-10 13:54:00-04:00,GNMK,positive
565388.0,82 Stocks Moving In Tuesday's Mid-Day Session,2020-03-10 12:25:00-04:00,GNMK,neutral
565389.0,Penny Stock Aytu Bioscience Skyrockets On COVID-19 Rapid Test Distribution Deal,2020-03-10 12:23:00-04:00,GNMK,neutral
565390.0,100 Biggest Movers From Friday,2020-03-09 05:25:00-04:00,GNMK,neutral
565391.0,60 Stocks Moving In Friday's Mid-Day Session,2020-03-06 12:11:00-05:00,GNMK,neutral
565392.0,23 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-03-06 07:56:00-05:00,GNMK,neutral
565393.0,101 Biggest Movers From Yesterday,2020-03-06 04:28:00-05:00,GNMK,neutral
565394.0,70 Stocks Moving In Thursday's Mid-Day Session,2020-03-05 12:25:00-05:00,GNMK,neutral
565395.0,"GenMark Diagnostics Director Kagnoff  Buys 10,000 @ Avg Price: $4.61",2020-03-05 11:52:00-05:00,GNMK,neutral
565396.0,92 Biggest Movers From Yesterday,2020-03-05 04:41:00-05:00,GNMK,neutral
565397.0,60 Stocks Moving In Wednesday's Mid-Day Session,2020-03-04 12:11:00-05:00,GNMK,neutral
565398.0,"Benzinga Pro's Top 5 Stocks To Watch For Wed., Mar. 4, 2020: JWN, VIR, CMG, AHPI, GNMK",2020-03-04 08:04:00-05:00,GNMK,positive
565399.0,36 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-03-04 08:00:00-05:00,GNMK,neutral
565400.0,38 Stocks Moving in Wednesday's Pre-Market Session,2020-03-04 07:18:00-05:00,GNMK,neutral
565401.0,85 Biggest Movers From Yesterday,2020-03-04 05:04:00-05:00,GNMK,neutral
565402.0,Mid-Afternoon Market Update: Dow Tumbles 800 Points; Superconductor Technologies Shares Spike Higher,2020-03-03 14:50:00-05:00,GNMK,positive
565403.0,Mid-Day Market Update: Dow Falls Over 200 Points; Fed Issues Emergency Interest Rate Cut,2020-03-03 12:17:00-05:00,GNMK,negative
565404.0,50 Stocks Moving In Tuesday's Mid-Day Session,2020-03-03 12:03:00-05:00,GNMK,neutral
565405.0,GenMark Spikes Higher On COVID-19 Test Kit Shipment,2020-03-03 10:22:00-05:00,GNMK,neutral
565406.0,Mid-Morning Market Update: Markets Open Higher; Target Posts Mixed Q4 results,2020-03-03 10:14:00-05:00,GNMK,neutral
565407.0,40 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2020-03-03 08:10:00-05:00,GNMK,neutral
565408.0,"The Daily Biotech Pulse: GenMark Diagnostics Ships COVID-19 Test Kits, Karyopharm To Offer Shares, And More",2020-03-03 07:51:00-05:00,GNMK,positive
565409.0,40 Stocks Moving in Tuesday's Pre-Market Session,2020-03-03 07:31:00-05:00,GNMK,neutral
565410.0,"Needham Maintains Buy on GenMark Diagnostics, Lowers Price Target to $11",2020-03-03 07:04:00-05:00,GNMK,negative
565411.0,15 Stocks Moving In Monday's After-Hours Session,2020-03-02 16:50:00-05:00,GNMK,neutral
565412.0,GenMark Diagnostics shares are trading higher after the company reported Q4 earnings results.,2020-03-02 16:12:00-05:00,GNMK,positive
565413.0,"GenMark Diagnostics Q4 EPS $(0.17) Misses $(0.16) Estimate, Sales $27.2M Miss $27.44M Estimate",2020-03-02 16:06:00-05:00,GNMK,negative
565414.0,"GenMark Diagnostics Reports Initial Shipments Of ePlex Research Use Only Test Kits Designed For Coronavirus, No Quantity Disclosed",2020-03-02 16:04:00-05:00,GNMK,negative
565415.0,"The Week Ahead In Biotech: COVID-19 Stocks In The Spotlight, Earnings Taper Off",2020-02-29 14:52:00-05:00,GNMK,neutral
565416.0,GenMark Notes Its Current Respiratory Panel Was Developed Before Existence Of COVID-19 And Can't Detect It,2020-02-28 12:24:00-05:00,GNMK,neutral
565417.0,86 Stocks Moving In Friday's Mid-Day Session,2020-02-28 12:19:00-05:00,GNMK,negative
565418.0,GenMark Diagnostics Site Shows Co. Has Coronavirus Test,2020-02-28 10:16:00-05:00,GNMK,neutral
565419.0,"The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO",2020-02-28 07:28:00-05:00,GNMK,neutral
565420.0,Stocks That Hit 52-Week Lows On Thursday,2020-02-27 10:23:00-05:00,GNMK,negative
565421.0,"The Daily Biotech Pulse: Gilead Kicks Off Coronavirus Drug Trials, Adcom Nod For Lily, FDA Approves Esperion's Lipid-Lowering Adjunctive Combo Therapy",2020-02-27 07:35:00-05:00,GNMK,positive
565422.0,"The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion",2020-02-21 07:46:00-05:00,GNMK,negative
565423.0,Stocks That Hit 52-Week Lows On Thursday,2020-02-20 10:54:00-05:00,GNMK,negative
565424.0,"The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study",2020-02-20 07:06:00-05:00,GNMK,negative
565425.0,Stocks That Hit 52-Week Lows On Wednesday,2020-02-19 10:44:00-05:00,GNMK,negative
565426.0,"The Daily Biotech Pulse: FDA Snub For Merck, Priority Review For Roche's Tecentriq sBLA",2020-02-19 07:21:00-05:00,GNMK,negative
565427.0,Stocks That Hit 52-Week Lows On Tuesday,2020-02-18 11:11:00-05:00,GNMK,negative
565428.0,"The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data",2020-02-12 09:18:00-05:00,GNMK,positive
565429.0,94 Biggest Movers From Yesterday,2020-02-12 05:13:00-05:00,GNMK,neutral
565430.0,Stocks That Hit 52-Week Lows On Tuesday,2020-02-11 11:05:00-05:00,GNMK,negative
565431.0,"Benzinga's Top Upgrades, Downgrades For February 11, 2020",2020-02-11 09:39:00-05:00,GNMK,positive
565432.0,Raymond James Downgrades GenMark Diagnostics to Market Perform,2020-02-11 05:11:00-05:00,GNMK,neutral
565433.0,"The Daily Biotech Pulse: Nektar Withdraws Opioid Pain Drug NDA, Galapagos Takes Stake In Fibrocor, Integra Lifesciences Lowers Q4 Guidance",2020-01-15 08:22:00-05:00,GNMK,negative
565434.0,GenMark Diagnostics Sees Q4 Sales $27M vs $27.6M Est,2020-01-13 07:09:00-05:00,GNMK,neutral
565435.0,GenMark Diagnostics Narrows FY2019 Sales Guidance from $85M-90M to $88M vs $88.3M Est,2020-01-13 07:08:00-05:00,GNMK,neutral
565436.0,"The Daily Biotech Pulse: Xeris Jumps On Positive Data, Mixed Results For Merck's Keytruda-Chemo Combo In Lung Cancer, Intra-Cellular Announces Offering",2020-01-07 07:57:00-05:00,GNMK,negative
565437.0,"Benzinga's Top Upgrades, Downgrades For December 11, 2019",2019-12-11 10:46:00-05:00,GNMK,positive
565438.0,"JP Morgan Downgrades GenMark Diagnostics to Neutral, Lowers Price Target to $7",2019-12-11 06:09:00-05:00,GNMK,positive
565439.0,"Raymond James Maintains Outperform on GenMark Diagnostics, Raises Price Target to $9",2019-11-07 12:33:00-05:00,GNMK,neutral
565440.0,GenMark Diagnostics Reaffirms FY2019 Sales Guidance of $85M-90M vs $87.86M,2019-11-06 17:03:00-05:00,GNMK,neutral
565441.0,"GenMark Diagnostics Q3 EPS $(0.2) Misses $(0.19) Estimate, Sales $20.918M Beat $20.59M Estimate",2019-11-06 17:02:00-05:00,GNMK,negative
565442.0,85 Biggest Movers From Yesterday,2019-08-07 05:39:00-04:00,GNMK,neutral
565443.0,GenMark Reaffirms FY19 Sales Guidance $85M-$90M vs $87.3M Estimate,2019-08-05 16:38:00-04:00,GNMK,neutral
565444.0,"GenMark Diagnostics Q2 EPS $(0.23) Misses $(0.21) Estimate, Sales $18.374M Beat $17.87M Estimate",2019-08-05 16:37:00-04:00,GNMK,negative
565445.0,GenMark Diagnostics Reaffirms FY19 Sales Guidance From $85M-$90M vs $86.86M Est.,2019-04-30 17:12:00-04:00,GNMK,neutral
565446.0,"GenMark Diagnostics Q1 EPS $(0.21) Misses $(0.2) Estimate, Sales $21.5M Beat $20.93M Estimate",2019-04-30 17:10:00-04:00,GNMK,negative
565447.0,"Shares of several healthcare stocks are trading higher in a potential rebound from last week's selloff. In an upgrade of HCA Healthcare, Raymond James analysts noted the selloff was 'based on legislation that has almost no chance of passing'",2019-04-23 11:52:00-04:00,GNMK,positive
565448.0,64 Biggest Movers From Yesterday,2019-04-18 05:17:00-04:00,GNMK,neutral
565449.0,42 Stocks Moving In Wednesday's Mid-Day Session,2019-04-17 12:35:00-04:00,GNMK,neutral
565450.0,GenMark Diagnostics Receives FDA 510(k) Market Clearance for its ePlex Blood Culture Identification Gram-Negative Panel,2019-04-15 07:35:00-04:00,GNMK,neutral
565451.0,71 Biggest Movers From Friday,2019-02-25 05:04:00-05:00,GNMK,neutral
565452.0,GenMark Sees FY19 Sales $85M-$90M vs $86.7M Estimate,2019-02-21 16:40:00-05:00,GNMK,neutral
565453.0,"GenMark Diagnostics Q4 EPS $(0.21) Misses $(0.17) Estimate, Sales $19.4M Beat $18.95M Estimate",2019-02-21 16:39:00-05:00,GNMK,negative
565454.0,GenMark Diagnostics Sees FY18 Sales $70.8M vs $70.05M Est.,2019-01-08 08:06:00-05:00,GNMK,neutral
565455.0,GenMark Bulls Emboldened By Accelerated ePlex Panel Clearance,2018-12-27 10:24:00-05:00,GNMK,neutral
565456.0,GenMark Diagnostics shares are trading higher after the company announced it received FDA 510(k) market clearance from the FDA for its ePlex Blood Culture Identification Fungal Pathogen Panel.,2018-12-26 13:47:00-05:00,GNMK,positive
565457.0,GenMark Diagnostics Receives FDA 510(k) Market Clearance For Its ePlex Blood Culture Identification Fungal Pathogen Panel,2018-12-26 08:03:00-05:00,GNMK,neutral
565458.0,"The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial",2018-12-21 07:58:00-05:00,GNMK,neutral
565459.0,GenMark Diagnostics Receives FDA 510(k) Market Clearance For ePlex Blood Culture Identification Gram-Positive Panel,2018-12-20 14:15:00-05:00,GNMK,neutral
565460.0,GenMark Diagnostics Form S Shows Filing For $150M Mixed Shelf Offering,2018-11-20 16:20:00-05:00,GNMK,neutral
565461.0,"GenMark Diagnostics Reaffirms FY18 Guidance, Sees FY18 Sales $68M-$72M vs $71M Est.",2018-10-29 16:14:00-04:00,GNMK,neutral
565462.0,"GenMark Diagnostics, Inc. Q3 EPS $(0.20), Inline, Sales $15.8M Beat $15.49M Estimate",2018-10-29 16:13:00-04:00,GNMK,neutral
565463.0,"GenMark Diagnostics Reports FDA Submission Of ePlex Blood Culture Identification Gram-Negative, ePlex Blood Culture Identification Fungal Pathogen Panels",2018-10-02 16:15:00-04:00,GNMK,neutral
565464.0,65 Biggest Movers From Yesterday,2018-08-01 04:36:00-04:00,GNMK,neutral
565465.0,52 Stocks Moving In Tuesday's Mid-Day Session,2018-07-31 12:38:00-04:00,GNMK,neutral
565466.0,"GenMark Diagnostics Inc. Shares Up 12% After Co. Announced Quarterly Financial Results Monday After Close; EPS $(0.30) Misses $(0.22) Estimate, Sales $14.94M Beat $14.5M Estimate",2018-07-31 11:15:00-04:00,GNMK,positive
565467.0,GenMark Diagnostics Reaffirms FY18 Sales Outlook; Sees FY18 Sales $68M-$72M vs $71.03M Est.,2018-07-30 16:39:00-04:00,GNMK,neutral
565468.0,"GenMark Diagnostics Q2 EPS $(0.30) Misses $(0.22) Estimate, Sales $14.94M Beat $14.5M Estimate",2018-07-30 16:38:00-04:00,GNMK,negative
565469.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings And IPOs",2018-07-28 14:04:00-04:00,GNMK,neutral
565470.0,"GenMark Diagnostics Q1 EPS $(0.21) Beats $(0.22) Estimate, Sales $20.6M Beat $17.25M Estimate",2018-05-01 16:47:00-04:00,GNMK,neutral
565471.0,36 Biggest Movers From Yesterday,2018-04-19 04:28:00-04:00,GNMK,neutral
565472.0,"GenMark Diagnostics 13D Filing From Casdin Capital Shows Raised Stake From 2.73M Shares At End Of Last Qtr. To 3.85M Shares, Or 7% Stake",2018-03-27 15:36:00-04:00,GNMK,positive
565473.0,50 Biggest Movers From Yesterday,2018-03-01 04:59:00-05:00,GNMK,neutral
565474.0,"GenMark Reports Q4 EPS $(0.26) vs $(0.26) Est., Sales $16.0M vs $15.6M Est.",2018-02-27 16:22:00-05:00,GNMK,neutral
565475.0,40 Biggest Movers From Yesterday,2018-01-24 05:38:00-05:00,GNMK,neutral
565476.0,GenMark Diagnostics Narrows FY2017 Sales Guidance from $51.0M-53.0M to $52.50M vs $51.68M Est,2018-01-09 07:14:00-05:00,GNMK,neutral
565477.0,30 Stocks Moving In Monday's Pre-Market Session,2017-12-04 08:12:00-05:00,GNMK,neutral
565478.0,57 Biggest Movers From Yesterday,2017-11-09 05:16:00-05:00,GNMK,neutral
565479.0,GenMark Diagnostics Shares Down 9.39%; Late Friday Several Form 4 Filings Showed Insider Selling; BZ NOTE: Each Of These Sales Were Made Pursuant To Pre-Established Trading Plans Meant To Satisfy Tax Obligations,2017-11-06 11:36:00-05:00,GNMK,positive
565480.0,55 Biggest Movers From Friday,2017-11-06 05:58:00-05:00,GNMK,neutral
565481.0,Mid-Afternoon Market Update: KEYW Drops Following Disappointing Q3 Results; Varonis Shares Surge,2017-11-03 14:31:00-04:00,GNMK,negative
565482.0,48 Stocks Moving In Friday's Mid-Day Session,2017-11-03 12:30:00-04:00,GNMK,neutral
565483.0,"GenMark Diagnostics Shares Down 29%, Halted On Circuit Breaker",2017-11-03 09:53:00-04:00,GNMK,positive
565484.0,Raymond James Downgrades GenMark Diagnostics to Market Perform,2017-11-03 08:23:00-04:00,GNMK,neutral
565485.0,GenMark Diagnostics Sees FY17 Sales $51M-$53M vs $64.05M Est.,2017-11-02 17:37:00-04:00,GNMK,neutral
565486.0,"GenMark Diagnostics Reports Q3 EPS $(0.28) vs $(0.26) Est., Sales $11.6M vs $14.56M Est.",2017-11-02 17:36:00-04:00,GNMK,neutral
565487.0,"Bank of America Initiates Coverage On GenMark Diagnostics with Buy Rating, Announces $13.00 Price Target",2017-09-18 09:40:00-04:00,GNMK,neutral
565488.0,Secondary Offering Lockup Expirations Today From Canada Goose and GenMark Diagnostics,2017-09-12 09:23:00-04:00,GNMK,neutral
565489.0,"BTIG Transitions Coverage Of GenMark Diagnostics, Establishes Buy Rating And $13 Price Target",2017-08-31 07:39:00-04:00,GNMK,neutral
565490.0,Mid-Afternoon Market Update: Crude Oil Down 2.5%; Horizon Global Shares Spike Higher,2017-08-01 14:30:00-04:00,GNMK,negative
565491.0,15 Biggest Mid-Day Losers For Tuesday,2017-08-01 13:10:00-04:00,GNMK,negative
565492.0,"Cowen Out Defending Genmark Diagnostics Following Gross Margins Coming In Materially Below Expectations, View Today's Weakness As A Buying Opportunity For The Stock As Outlook Is Unchanged",2017-08-01 12:28:00-04:00,GNMK,negative
565493.0,Mid-Day Market Update: Pitney Bowes Drops On Earnings Miss; Lumber Liquidators Shares Climb,2017-08-01 12:03:00-04:00,GNMK,positive
565494.0,"GenMark Reports Q2 EPS $(0.37) vs $(0.32) Est., Sales $12.4M vs $12.41M Est.",2017-08-01 08:06:00-04:00,GNMK,neutral
565495.0,"GenMark Diagnostics Reports Achieved CE Mark For ePlex Blood Culture ID Gram-Positive, Gram-Negative Panels",2017-06-29 16:33:00-04:00,GNMK,neutral
565496.0,GenMark Reports Commencement Of $65M In Common Stock,2017-06-12 16:02:00-04:00,GNMK,neutral
565497.0,"GenMark Reports Received FDA 510(k) Market Clearance For ePlex Instrument, Respiratory Pathogen Panel",2017-06-12 08:05:00-04:00,GNMK,neutral
565498.0,GenMark Diagnostics Sees FY17 Sales $65M-$70M vs $67M Est.,2017-05-02 17:37:00-04:00,GNMK,neutral
565499.0,"GenMark Reports Q1 EPS $(0.30) vs $(0.28) Est., Sales $12.5M vs $12.45M Est.",2017-05-02 17:15:00-04:00,GNMK,neutral
565500.0,GenMark Diagnostics Reports Achieved CE Mark for ePlex Blood Culture ID Fungal Pathogen Panel,2017-04-20 16:32:00-04:00,GNMK,neutral
565501.0,"GenMark Diagnostics Reports Q4 EPS $(0.27) In-line, Sales $14.9M vs $14.83M Est.",2017-02-28 16:41:00-05:00,GNMK,neutral
565502.0,GenMark Q4 Revenue $14.8M vs $14.8M Est,2017-01-10 08:05:00-05:00,GNMK,neutral
565503.0,GenMark Diagnostics Submits 510(k) Applications to the FDA for ePlex,2016-12-22 08:05:00-05:00,GNMK,neutral
565504.0,GenMark Sees FY16 Rev. $47-$51M vs. Est. $49M,2016-11-03 17:39:00-04:00,GNMK,neutral
565505.0,"GenMark Reports Q3 EPS $(0.27) vs. Est. $(0.31), Rev. $10.8M vs. Est. $10.36M",2016-11-03 17:39:00-04:00,GNMK,neutral
565506.0,"25 Stocks Which Rallied Four Days, Then Sold Off Yesterday",2016-09-22 09:47:00-04:00,GNMK,neutral
565507.0,Mid-Afternoon Market Update: Dow Falls 100 Points; Crude Oil Down 2.3%,2016-09-16 14:33:00-04:00,GNMK,negative
565508.0,12 Biggest Mid-Day Gainers For Friday,2016-09-16 12:39:00-04:00,GNMK,neutral
565509.0,Mid-Day Market Update: Novavax Tumbles Following Failed Trial; Depomed Shares Surge,2016-09-16 12:19:00-04:00,GNMK,negative
565510.0,Investors Taking Note Of Cowen's GenMark Diagnostics Upgrade,2016-09-16 11:15:00-04:00,GNMK,neutral
565511.0,Benzinga's Volume Movers,2016-09-16 10:27:00-04:00,GNMK,neutral
565512.0,Mid-Morning Market Update: Markets Open Lower; Intel Lifts Q3 Revenue Outlook,2016-09-16 10:05:00-04:00,GNMK,negative
565513.0,12 Stocks Moving In Friday's Pre-Market Session,2016-09-16 08:21:00-04:00,GNMK,neutral
565514.0,Cowen & Co. Upgrades GenMark Diagnostics to Outperform,2016-09-16 06:18:00-04:00,GNMK,neutral
565515.0,GenMark Sees FY16 Rev. $47-$51M vs. Est. $47M,2016-07-28 16:12:00-04:00,GNMK,neutral
565516.0,"GenMark Diagnostics Reports Q2 EPS $(0.30) vs. Est. $(0.33), Rev. $12.5M vs. Est. $9.62M",2016-07-28 16:11:00-04:00,GNMK,neutral
565517.0,UPDATE: StreetSweeper on Genmark: 'Seven Signs of Sickness',2016-07-07 09:56:00-04:00,GNMK,neutral
565518.0,UPDATE: ALERT: TheStreetSweeper issues a new report on GenMark Diagnostics (GNMK)!,2016-07-07 09:55:00-04:00,GNMK,positive
565519.0,StreetSweeper to Issue Alert on GenMark,2016-07-07 09:55:00-04:00,GNMK,positive
565520.0,"GenMark, T2 And Accelerate Diagnostics Impress Analysts At Microbiology Forum",2016-06-27 11:35:00-04:00,GNMK,positive
565521.0,GenMark Reports Received CE Mark for ePlex Sample-to-Answer System,2016-06-08 16:05:00-04:00,GNMK,neutral
565522.0,Mid-Day Market Update: ServiceNow Jumps On Strong Q1 Results; Trueblue Shares Slide,2016-04-21 12:04:00-04:00,GNMK,positive
565523.0,GenMark Sees FY16 Sales $47M-$51M vs $48.5M Est.,2016-02-23 16:29:00-05:00,GNMK,neutral
565524.0,"GenMark Reports Q4 EPS $(0.21) vs $(0.27) Est., Sales $13.2M vs $12.3M Est.",2016-02-23 16:28:00-05:00,GNMK,neutral
565525.0,6 Stocks Moving On Monday's After-Hours Session,2016-02-22 17:16:00-05:00,GNMK,neutral
565526.0,GenMark Sees Prelim Q4 Revs $13.2M Vs Est $12.34M; Sees FY 2015 Revs $39.4M vs Est $38.56M; Says XT-8 Installed Base Grew By 17 to 633,2016-01-12 16:06:00-05:00,GNMK,neutral
565527.0,"Genmark Diagnostics CFO Mendel Buys 10,000 Shares @$6.47/Share -Form 4",2015-11-02 11:42:00-05:00,GNMK,positive
565528.0,Stocks Hitting 52-Week Lows,2015-10-28 10:28:00-04:00,GNMK,negative
565529.0,Morning Market Losers,2015-10-28 09:57:00-04:00,GNMK,negative
565530.0,Genmark Diagnostic Shares Down ~30%,2015-10-28 09:51:00-04:00,GNMK,positive
565531.0,"GenMark Diagnostics Reports Q3 Loss $0.27 Vs Est Loss $0.37, Sales $8.47M Vs Est $8.24M; Reaffirms 2015 Revs $38M-$40M Vs Est $38.43M",2015-10-27 16:27:00-04:00,GNMK,negative
565532.0,"GenMark Diagnostics Reports Q3 EPS $(0.27) vs. Est. $(0.31), Rev. $8.5M vs. Est. $8.24M",2015-10-27 16:07:00-04:00,GNMK,neutral
565533.0,"GenMark Reports Q2 EPS $(0.29) vs. Est. $(0.31), Rev. $7.6M vs. Est. $7.59M",2015-08-06 17:53:00-04:00,GNMK,neutral
565534.0,Option Alert: Genmark Diagnostics Sep $10 Call; 1500 Contracts Above Ask @$0.22,2015-08-06 15:42:00-04:00,GNMK,positive
565535.0,Mid-Afternoon Market Update: Standard Pacific Rises On Ryland Merger Deal; Micron Shares Slip,2015-06-15 15:58:00-04:00,GNMK,positive
565536.0,Mid-Afternoon Market Update: Wingstop Shares Surge in Stock Market Debut; ExOne Shares Tumble,2015-06-12 15:17:00-04:00,GNMK,positive
565537.0,GenMark Announces Preliminary Q1 Rev. Of $10.1M; FY15 Rev. Between $38-40M,2015-04-16 16:10:00-04:00,GNMK,neutral
565538.0,"GenMark Reports Q4 EPS -$0.21 Vs -$0.28, Sales $9.83M Vs Est $9.12M",2015-02-24 16:10:00-05:00,GNMK,neutral
565539.0,GenMark Diagnostics Reports Prelim Q4 Sales $9.80M,2015-01-12 16:07:00-05:00,GNMK,neutral
565540.0,GenMark Announces Completion of ePlex; Expects Q4 Revenue Of $9.8M,2015-01-12 16:06:00-05:00,GNMK,neutral
565541.0,"GenMark Diagnostics, Inc. Reports Q2 EPS of $(0.03) vs $(0.29) Est; Revenue of $6.56M vs $4.79M Est",2014-08-11 16:18:00-04:00,GNMK,neutral
565542.0,Upcoming Corporate Events/Presentations for the Week of Aug. 11-15th,2014-08-11 11:54:00-04:00,GNMK,neutral
565543.0,"GenMark Diagnostics, Inc. Reports Prelim Q2 Sales $6.60M vs $4.79M Est",2014-07-28 16:06:00-04:00,GNMK,neutral
565544.0,Genmark Announces Scott Mendel CFO,2014-05-12 16:06:00-04:00,GNMK,neutral
565545.0,"GenMark Diagnostics, Inc. Reports Q4 EPS of $(0.26) vs $(0.22) Est; Revenue of $6.45M vs $6.06M Est",2014-03-11 16:06:00-04:00,GNMK,neutral
565546.0,"Needham Initiates Coverage on GenMark Diagnostics, Inc. at Buy, Announces $17.00 PT",2013-12-19 08:26:00-05:00,GNMK,neutral
565547.0,"GenMark Diagnostics, Inc. Reports Q3 EPS of $(0.30) vs $(0.27) Est; Revenue of $4.64M vs $4.60M Est",2013-11-12 16:03:00-05:00,GNMK,neutral
565548.0,GenMark Shares Push Over $12 Level Following Mid-day Raised Price Target to $15 at Raymond James,2013-10-02 14:17:00-04:00,GNMK,positive
565549.0,Benzinga's Top Pre-Market Gainers,2013-08-14 08:07:00-04:00,GNMK,positive
565550.0,GenMark Diagnostics Announces Proposed Public Offering of $60 Million of Common Stock ,2013-08-12 16:01:00-04:00,GNMK,neutral
565551.0,"GenMark Diagnostics, Inc. Reports Q2 EPS of $(0.25) vs $(0.26) Est; Revenue of $5.22M vs $5.05M Est",2013-08-07 16:28:00-04:00,GNMK,neutral
565552.0,"Market Wrap for Tuesday, June 18: Stocks Rally Ahead of Fed Statement ",2013-06-18 16:22:00-04:00,GNMK,neutral
565553.0,UPDATE: J.P. Morgan Lowers PT on GenMark Diagnostics on Lowered 2013 Guidance,2013-06-18 14:16:00-04:00,GNMK,negative
565554.0,Afternoon Market Losers,2013-06-18 12:35:00-04:00,GNMK,negative
565555.0,"JP Morgan Maintains Overweight on GenMark Diagnostics, Inc., Lowers PT to $15.00",2013-06-18 09:19:00-04:00,GNMK,negative
565556.0,Benzinga's Top Pre-Market Losers,2013-06-18 08:25:00-04:00,GNMK,negative
565557.0,"Benzinga Market Primer: Tuesday, June 18",2013-06-18 06:20:00-04:00,GNMK,neutral
565558.0,US Stock Futures Up; Inflation Data In Focus,2013-06-18 06:19:00-04:00,GNMK,neutral
565559.0,"UPDATE: Genmark Cuts Annual Revenue Guidance, Shares Slide",2013-06-17 16:32:00-04:00,GNMK,neutral
565560.0,Genmark Lowers Annual Revenue Guidance to $30 Million From $35 Million Prior,2013-06-17 16:06:00-04:00,GNMK,negative
565561.0,Afternoon Market Losers,2013-06-12 14:10:00-04:00,GNMK,negative
565562.0,Mid-Afternoon Market Update: Markets Turn Red as Dole Offer Sends Shares Soaring,2013-06-11 15:20:00-04:00,GNMK,positive
565563.0,Afternoon Market Losers,2013-06-11 13:24:00-04:00,GNMK,negative
565564.0,"GenMark Diagnostics, Inc. Reports Q1 EPS of $(0.13) vs $(0.17) Est; Revenue of $11.10M vs $9.53M Est",2013-05-08 17:25:00-04:00,GNMK,neutral
565565.0,"Cowen & Company Initiates Coverage on GenMark Diagnostics, Inc. at Outperform",2013-04-22 08:20:00-04:00,GNMK,neutral
565566.0,"Canaccord Genuity Maintains Buy on GenMark Diagnostics, Inc., Raises PT to $18.00",2013-04-15 10:55:00-04:00,GNMK,neutral
565567.0,UPDATE: J.P. Morgan Raises PT on GenMark Diagnostics on Strong 4Q12 Revenue,2013-03-13 12:18:00-04:00,GNMK,positive
565568.0,"JP Morgan Maintains Overweight on GenMark Diagnostics, Inc., Raises PT to $13.00",2013-03-13 08:27:00-04:00,GNMK,neutral
565569.0,"GenMark Diagnostics, Inc. Sees FY2013 Sales $35.0M vs $30.60M Est",2013-03-12 16:16:00-04:00,GNMK,neutral
565570.0,"GenMark Diagnostics, Inc. Reports Q4 EPS of $(0.15) vs $(0.21) Est",2013-03-12 16:16:00-04:00,GNMK,neutral
565571.0,"From Earlier: Raymond James Initiates Coverage on GenMark Diagnostics, Inc. at Outperform, Announces $12.00 PT",2012-12-21 11:00:00-05:00,GNMK,neutral
565572.0,Genmark Diagnostics Reports Q2 EPS $-0.26 vs $-0.27 Est; Revenues $3.61M vs $3.13M Est,2012-08-07 17:25:00-04:00,GNMK,neutral
565573.0,GenMark Diagnostics and Advanced Liquid Logic Finalize Technology and Collaboration Agreements to Develop an All-Digital Fully Integrated Diagnostic Platform   ,2012-07-31 09:02:00-04:00,GNMK,positive
565574.0,UPDATE: J.P. Morgan Initiates Coverage on GenMark Diagnostics,2012-07-12 10:09:00-04:00,GNMK,neutral
565575.0,"JP Morgan Initiates Coverage on Genmark Diagnostics at Overweight, Announces PT of $8",2012-07-12 05:53:00-04:00,GNMK,neutral
565576.0,Benzinga's Top Pre-Market Gainers,2012-06-21 08:08:00-04:00,GNMK,positive
565577.0,GenMark Diagnostics Announces Proposed Public Offering of 10M Shares,2012-06-19 16:20:00-04:00,GNMK,positive
565578.0,Top Narrow Based Indexes For June 12,2012-06-12 10:05:00-04:00,GNMK,positive
565579.0,GenMark Diagnostics Increases 2012 Revenue Guidance   ,2012-06-12 09:01:00-04:00,GNMK,neutral
565580.0,A Peek Into The Market Before The Trading Starts,2012-04-05 07:27:00-04:00,GNMK,neutral
565581.0,GenMark and Advanced Liquid Logic Enter into Agreement to Develop an All-Electronic Fully Integrated Diagnostic Platform   ,2012-04-05 06:43:00-04:00,GNMK,positive
565582.0,GenMark Diagnostics Appoints Richard B. Slansky Chief Financial Officer   ,2012-04-02 16:30:00-04:00,GNMK,neutral
565583.0,GenMark Submits Respiratory Viral Panel Test for FDA 510(k) Clearance,2011-12-21 14:56:00-05:00,GNMK,neutral
565584.0,GenMark Diagnostics Gas Reports Q2 EPS $(0.39) vs $(0.53) Est; Revenues $901K vs $860.00K Est,2011-08-05 07:16:00-04:00,GNMK,neutral
565585.0,GenMark Diagnostics Trading Over 40% Higher ,2011-06-17 09:39:00-04:00,GNMK,neutral
565586.0,UPDATE: GenMark Pricing Public Offering of 7.07M Shares at $4.25,2011-06-17 08:33:00-04:00,GNMK,positive
565587.0,GenMark Pricing Public Offering of 7.07M Shares at $4.25   ,2011-06-17 08:31:00-04:00,GNMK,positive
565588.0,William Blair & Co. Initiates Outperform Rating on GenMark Diagnostics (GNMK),2010-07-12 09:59:00-04:00,GNMK,neutral
